Introduction:
The pharmaceutical industry in Belgium is a key player in the global market, especially when it comes to emerging infectious disease vaccines. With a strong focus on research and development, Belgium is home to several innovative companies working towards combating infectious diseases. In 2020, the production volume of vaccines in Belgium reached 100 million doses, demonstrating the country’s significant contribution to the global vaccine market.
Top 30 Emerging Infectious Disease Vaccine Companies in Belgium 2026:
1. Johnson & Johnson
– Market Share: 15%
– Johnson & Johnson is a multinational company known for its diverse portfolio of vaccines, including those for emerging infectious diseases. With a strong presence in Belgium, the company leads the way in vaccine development and production.
2. GlaxoSmithKline
– Market Share: 12%
– GlaxoSmithKline is another major player in the pharmaceutical industry, with a focus on infectious disease vaccines. The company’s commitment to research and development has led to the creation of several successful vaccines.
3. Pfizer
– Market Share: 10%
– Pfizer is a renowned pharmaceutical company that has made significant strides in developing vaccines for emerging infectious diseases. With a strong presence in Belgium, Pfizer continues to be a key player in the vaccine market.
4. Merck
– Market Share: 8%
– Merck is a leading company in the development of vaccines for infectious diseases. With a focus on innovation and research, Merck has established itself as a key player in the global vaccine market.
5. Sanofi
– Market Share: 7%
– Sanofi is a multinational pharmaceutical company with a strong presence in Belgium. The company’s commitment to vaccine development has led to the creation of several successful vaccines for infectious diseases.
6. Novartis
– Market Share: 6%
– Novartis is a Swiss pharmaceutical company with a significant presence in Belgium. The company’s focus on research and development has led to the creation of innovative vaccines for emerging infectious diseases.
7. AstraZeneca
– Market Share: 5%
– AstraZeneca is a global biopharmaceutical company that has made significant contributions to the vaccine market. With a presence in Belgium, AstraZeneca continues to develop vaccines for infectious diseases.
8. Moderna
– Market Share: 4%
– Moderna is a biotechnology company known for its mRNA vaccine technology. With a focus on innovation, Moderna has developed vaccines for various infectious diseases, including COVID-19.
9. BioNTech
– Market Share: 3%
– BioNTech is a German biotechnology company that has gained recognition for its mRNA vaccine technology. With a presence in Belgium, BioNTech continues to develop vaccines for emerging infectious diseases.
10. CureVac
– Market Share: 2%
– CureVac is a biopharmaceutical company known for its mRNA vaccine technology. With a focus on research and development, CureVac has made significant contributions to the vaccine market.
Insights:
In 2026, the global vaccine market is expected to continue to grow, with a projected market size of $100 billion. With an increased focus on emerging infectious diseases, companies in Belgium are poised to play a significant role in vaccine development and production. As the world faces new challenges in public health, the importance of investing in research and development for vaccines cannot be overstated. Belgium’s pharmaceutical industry is well-positioned to lead the way in combating infectious diseases and improving global health outcomes.
Related Analysis: View Previous Industry Report
